Cited by 195Coenzyme Q10 studies and effectsLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

Statin therapy and plasma coenzyme Q10 concentrations—A systematic review and meta-analysis of placebo-controlled trials

Banach, Maciej, Serban, Corina, Ursoniu, Sorin, Rysz, Jacek, Muntner, Paul, Toth, Peter P., Jones, Steven R., Rizzo, Manfredi +6 more·2015·Pharmacological Research

Abstract

Statin therapy may lower plasma coenzyme Q10 (CoQ10) concentrations, but the evidence as to the significance of this effect is unclear. We assessed the impact of statin therapy on plasma CoQ10 concentrations through the meta-analysis of available RCTs. The literature search included selected databases up to April 30, 2015. The meta-analysis was performed using either a fixed-effects or random-effect model according to I(2) statistic. Effect sizes were expressed as weighted mean difference (WMD) and 95% confidence interval (CI). The data from 8 placebo-controlled treatment arms suggested a significant reduction in plasma CoQ10 concentrations following treatment with statins (WMD: -0.44 μmol/L, 95%CI: -0.52, -0.37, p<0.001). The pooled effect size was robust and remained significant in the leave-one-out sensitivity analysis. Subgroup analysis suggested that the impact of statins on plasma CoQ10 concentrations is significant for all 4 types of statins studied i.e. atorvastatin (WMD: -0.41 μmol/L, 95%CI: -0.53, -0.29, p<0.001), simvastatin (WMD: -0.47 μmol/L, 95% CI: -0.61, -0.33, p<0.001), rosuvastatin (WMD: -0.49 μmol/L, 95%CI: -0.67, -0.31, p<0.001) and pravastatin (WMD: -0.43 μmol/L, 95%CI: -0.69, -0.16, p=0.001). Likewise, there was no differential effect of lipophilic (WMD: -0.43 μmol/L, 95%CI: -0.53, -0.34, p<0.001) and hydrophilic statins (WMD: -0.47 μmol/L, 95%CI: -0.62, -0.32, p<0.001). With respect to treatment duration, a significant effect was observed in both subsets of trials lasting <12 weeks (WMD: -0.51 μmol/L, 95%CI: -0.64, -0.39, p<0.001) and ≥12 weeks (WMD: -0.40 μmol/L, 95%CI: -0.50, -0.30, p<0.001). The meta-analysis showed a significant reduction in plasma CoQ10 concentrations following treatment with statins. Further well-designed trials are required to confirm our findings and elucidate their clinical relevance.

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2015.07.008

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

2 of the 50 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Banach, M., Serban, C., Ursoniu, S., Rysz, J., Muntner, P., Toth, P. P., Jones, S. R., Rizzo, M., Glasser, S. P., Watts, G. F., Blumenthal, R. S., Lip, G. Y. H., Mikhailidis, D. P., & Sahebkar, A.
Affiliations
  • Medical University of Lodz (PL)
  • Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
  • University of Alabama at Birmingham (US)
  • Johns Hopkins University (US)
  • Johns Hopkins Medicine (US)
  • University of Palermo (IT)
  • The University of Western Australia (AU)
  • Birmingham City Hospital (GB)
  • The Royal Free Hospital (GB)
  • Mashhad University of Medical Sciences (IR)
Corresponding author
Banach, Maciej
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2015-09
Volume
99
Pages
329-336
ISSN
1043-6618 (ISSN-L)
OpenAlex
W1022878726
Cited by
195
References
50
Citations by year
2026: 8 · 2025: 17 · 2024: 12 · 2023: 26 · 2022: 22 · 2021: 18 · 2020: 19 · 2019: 3 · 2018: 17 · 2017: 22 · 2016: 25 · 2015: 5
FWCI
2.23
Type
journal article
Language
en
Open access
closed
Locations
  • Pharmacological Research (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
  • Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
statins, coenzyme Q10, atorvastatin, simvastatin, rosuvastatin, pravastatin, treatment duration, statin safety
MeSH terms
Adult, Aged, Double-Blind Method, Female, Humans, Male, Middle Aged, Ubiquinone, Placebo Effect, Case-Control Studies, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review